# Perceval S Aortic Heart Valve Study- North America

Study · id `cardio:ct-nct01810679` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01810679](<https://clinicaltrials.gov/study/NCT01810679>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01810679

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 355 participants.

## Technical summary

Registry record NCT01810679. Allocation not applicable; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2016-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 355 participants (enrolled count; ClinicalTrials.gov record NCT01810679, source copy `cardio:ctgov-nct01810679-2016-11-16`, retrieved 2026-10-26)
- Start date: 2013-04 (registry gives no type) (ClinicalTrials.gov record NCT01810679, source copy `cardio:ctgov-nct01810679-2016-11-16`, retrieved 2026-10-26)
- Primary completion: 2016-02 (actual) (ClinicalTrials.gov record NCT01810679, source copy `cardio:ctgov-nct01810679-2016-11-16`, retrieved 2026-10-26)
- Completion: 2018-04 (anticipated) (ClinicalTrials.gov record NCT01810679, source copy `cardio:ctgov-nct01810679-2016-11-16`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01810679, source copy `cardio:ctgov-nct01810679-2016-11-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01810679-2016-11-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Perceval S Aortic Heart Valve Study- North America
- Condition: Aortic Valve Stenosis
- Condition: Aortic Valve Stenosis With Insufficiency
- Condition: Regurgitation, Aortic Valve
- Condition: Aortic Valve Incompetence
- Intervention (Device): Perceval S Aortic Heart Valve
- Lead sponsor: Sorin Group USA, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic regurgitation (`cardio:aortic-regurgitation`)
- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 7955ab155da7ff66b78062bfcae02bebf5a7746015e97b00d8d5a10ce031ed8f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
